Jones Financial Companies
NVAX icon

Jones Financial Companies’s Novavax NVAX Stock Holding History

Jones Financial Companies’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.2K Sell
9,254
-5,046
-35% -$45.2K ﹤0.01% 2926
2026
Q1 		$121K Buy
14,300
+6,115
+75% +$55.4K ﹤0.01% 2600
2025
Q4 		$55K Buy
8,185
+1,811
+28% +$13.7K ﹤0.01% 2474
2025
Q3 		$54.5K Buy
6,374
+804
+14% +$6.26K ﹤0.01% 2342
2025
Q2 		$35.5K Buy
5,570
+2,826
+103% +$18.7K ﹤0.01% 2358
2025
Q1 		$19.2K Buy
2,744
+632
+30% +$5.22K ﹤0.01% 2444
2024
Q4 		$17K Sell
2,112
-168
-7% -$1.62K ﹤0.01% 2321
2024
Q3 		$30.3K Buy
2,280
+1,443
+172% +$18.6K ﹤0.01% 1815
2024
Q2 		$10.6K Buy
+837
New +$8.42K ﹤0.01% 1743

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Jones Financial Companies's NVAX Position: Q2 2026 in Review

Jones Financial Companies reduced its Novavax (NVAX) stake by 35% in Q2 2026, selling an estimated $45.2K and leaving 9,254 shares worth $82.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2926.

Jones Financial Companies first reported a position in NVAX in Q2 2024 and has held it in 9 quarters since. The position peaked at $121K in Q1 2026. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Jones Financial Companies held 9,254 shares of Novavax worth $82.2K as of Q2 2026.
  • Jones Financial Companies sold 5,046 Novavax shares in Q2 2026, an estimated $45.2K.
  • Novavax made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2926 holding.
  • Jones Financial Companies first reported a position in Novavax in Q2 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's Novavax position peaked at $121K in Q1 2026.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.